Previous 10 | Next 10 |
2024-05-02 09:01:39 ET More on Allarity Therapeutics Allarity Therapeutics receives Nasdaq-approved extension to regain compliance Seeking Alpha’s Quant Rating on Allarity Therapeutics Historical earnings data for Allarity Therapeutics Financial inform...
Boston (May 2, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced the early discontinuation of its Phase 2 clinical tri...
2024-04-29 09:21:40 ET More on Allarity Therapeutics Allarity Therapeutics receives Nasdaq-approved extension to regain compliance Seeking Alpha’s Quant Rating on Allarity Therapeutics Historical earnings data for Allarity Therapeutics Financial inform...
Boston (April 29, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that on April 27, 2024, it received formal notic...
2024-04-19 10:00:25 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Short interest in S&P 500 health stocks rises, Moderna among m...
2024-04-17 09:19:37 ET More on Allarity Therapeutics Seeking Alpha’s Quant Rating on Allarity Therapeutics Historical earnings data for Allarity Therapeutics Financial information for Allarity Therapeutics Read the full article on Seeking Alpha ...
Boston (April 17, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that it had been granted an extension until May 14...
2024-04-15 08:41:18 ET More on premarket gainers & stock Carvana, Vroom, BuzzFeed, Encore Wire - Getting Paid To Take Risks With Courage & Conviction Investing U.S. Energy Corp. (USEG) Q4 2023 Earnings Call Transcript Cutera, Inc. (CUTR) Q4 2023 Earnings Call...
Allarity Therapeutics Inc (NASDAQ: ALLR) is one of today's top gainers. The company's shares have moved 20.87% on the day to $2.78. Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics gen...
A look at the top 10 most actives in the United States Beneficient (BENF) rose 44.7% to $0.1 on volume of 79,601,246 shares PaxMedica Inc. (PXMD) rose 123.0% to $0.9183 on volume of 54,446,384 shares NextPlat Corp (NXPL) rose 40.0% to $2.1 on volume of 30,284,097 shares Direxion Daily S...
News, Short Squeeze, Breakout and More Instantly...
Allarity Therapeutics Inc. Company Name:
ALLR Stock Symbol:
NASDAQ Market:
Allarity Therapeutics Inc. Website:
Current Cash Balance of $20 million Expected to Provide Runway Into 2026 Allarity to Pause Use of ATM Cap Table Successfully Cleaned Up Allarity’s Stenoparib Shows Extended Duration of Phase 2 Clinical Benefit Boston (July 22, 2024)—Allarity The...
Boston (June 27, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that it received notice from the NASDAQ S...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 6.8% to $126.09 on volume of 414,790,976 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 18.7% to $0.265 on volume of 162,165,405 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) fell 12.6%...